Quick Takeaways
- Andera Partners filed SCHEDULE 13G for EVOMMUNE, INC. Common Stock, $0.0001 par value per share.
- Disclosed ownership: 6%.
- Date of event: 07 Nov 2025.
Andera Partners - 07 Nov 2025 SCHEDULE 13G Report for EVOMMUNE, INC. Common Stock, $0.0001 par value per share
- Filing Manager
- Andera Partners
- Reporting Manager
- Andera Partners
- Shares outstanding
- 31,622,700 shares
- Disclosed Ownership
- 1,897,362 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Nov 2025, 16:33:13 UTC
- Date of event
- 07 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Andera Partners disclosed 6% ownership in EVOMMUNE, INC. Common Stock, $0.0001 par value per share on 07 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Nov 2025, 16:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Andera Partners | 6% | 1,897,362 | 0 | 1,897,362 | /s/ Stephane Bergez | By Stephane Bergez, Managing Partner | |
| BioDiscovery 6 FPCI | 6% | 1,897,362 | 0 | 1,897,362 | /s/ Stephane Bergez | By Andera Partners, its management company, By Stephane Bergez, Managing Partner | |
| Stephane Bergez | 6% | 1,897,362 | 0 | 1,897,362 | /s/ Stephane Bergez | Stephane Bergez | |
| Francois Xavier Mauron | 6% | 1,897,362 | 0 | 1,897,362 | /s/ Francois Xavier Mauron | Francois Xavier Mauron |